Our Pricing

Weight Loss Clinic Preston: Expert Prescription Treatment & Online Consultation

Published: 30 September 2026

Finding a trusted weight loss clinic Preston residents can rely on has become simpler with online pharmacy services offering prescription treatments like Mounjaro, Wegovy, and Saxenda. At Cured Pharmacy, our UK-registered clinical team provides free online consultations under three minutes, connecting Preston patients with genuine weight loss medications from £124.99. All treatments require clinical assessment by a UK prescriber to ensure safety and suitability for your individual health profile.

How Our Weight Loss Clinic Preston Service Works

Our weight loss clinic Preston service operates entirely online, eliminating the need for in-person appointments while maintaining the highest clinical standards. You complete a confidential medical questionnaire reviewed by our UK-registered prescribers, who assess your eligibility for treatments including Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide). The entire consultation process takes under three minutes, with most patients receiving a decision within hours.

Once approved, your prescription is dispensed by our GPhC-registered pharmacy (9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Medications are delivered discreetly to your Preston address, typically within 24-48 hours. This streamlined approach provides Preston residents with the same clinical rigour as traditional weight loss clinics, but with significantly greater convenience and transparent upfront pricing[1].

Weight Loss Clinic Preston: Available Prescription Treatments

Our weight loss clinic Preston service offers the full spectrum of MHRA-licensed prescription treatments. Mounjaro (tirzepatide) represents the newest generation of weight loss injections, with SURMOUNT-1 trial data showing average weight reductions of 20.9% over 72 weeks at the 15mg dose[2]. Wegovy (semaglutide) demonstrated 14.9% average weight loss in the STEP 1 trial, whilst Saxenda (liraglutide) achieved 8% average weight reduction in clinical studies[3].

For patients preferring oral medications, we stock Wegovy oral tablets (semaglutide pill) from £124.99, alongside fat absorption inhibitors like Orlistat from £124.99 and Xenical from £124.99. Each treatment works through different mechanisms—GLP-1 receptor agonists like Mounjaro and Wegovy reduce appetite and slow gastric emptying, whilst Orlistat prevents approximately 30% of dietary fat absorption[4]. Your prescriber will recommend the most suitable option based on your medical history, BMI, and weight loss goals.

Injectable vs Oral Weight Loss Medications

Injectable treatments (Mounjaro, Wegovy, Saxenda) typically deliver superior weight loss outcomes compared to oral alternatives, though they require weekly or daily self-administration. Wegovy oral tablets offer a needle-free alternative with comparable efficacy to injectable semaglutide, making them ideal for needle-averse patients. Orlistat-based treatments work through a completely different mechanism and suit patients who prefer to avoid GLP-1 medications or have contraindications to incretin therapies.

Weight Loss Clinic Preston Pricing and Discount Codes

Transparent pricing distinguishes our weight loss clinic Preston service from competitors. Mounjaro starts at £124.99, Wegovy injections from £124.99, and Saxenda from £124.99—all prices displayed before consultation. New patients receive £20 off their first order using code Weightlossnew, reducing Mounjaro to £124.99 and Wegovy to £124.99 for initial purchases.

Unlike traditional weight loss clinics charging separate consultation fees, our clinical assessment is completely free. You only pay for medication if approved, with no hidden charges for prescriber reviews or follow-up consultations. This pricing structure ensures Preston patients can access prescription weight loss treatments at genuinely competitive rates whilst receiving full clinical oversight from UK-registered healthcare professionals[5].

Clinical Eligibility for Weight Loss Clinic Preston Treatments

Prescription weight loss medications available through our weight loss clinic Preston service require specific clinical criteria. NICE guidelines recommend GLP-1 treatments for adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea[6]. Your online assessment evaluates BMI, medical history, current medications, and contraindications to determine suitability.

Patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease typically cannot use GLP-1 treatments. Pregnant or breastfeeding women, and those planning pregnancy within three months, should not commence these medications. Our prescribers assess each application individually, recommending alternative treatments like Orlistat when GLP-1 medications are contraindicated.

Medical Conditions Affecting Treatment Selection

Patients with type 2 diabetes often achieve dual benefits from tirzepatide and semaglutide—both weight loss and improved glycaemic control, with HbA1c reductions of 2.0% and 1.7% respectively in clinical trials[7]. Those with cardiovascular disease may particularly benefit from semaglutide, which demonstrated 26% reduction in major adverse cardiovascular events in the SELECT trial. Your prescriber considers these factors when recommending the optimal treatment for your individual health profile.

What to Expect from Weight Loss Clinic Preston Consultations

Your weight loss clinic Preston online consultation begins with a comprehensive medical questionnaire covering weight history, previous weight loss attempts, current health conditions, and medications. Be prepared to provide accurate height and weight measurements for BMI calculation, as this directly impacts treatment eligibility. The assessment typically takes under three minutes to complete, though you should allocate time to answer questions thoroughly and honestly.

Our UK prescribers review submissions within hours, not days. If approved, you receive immediate confirmation with prescription details and delivery timeframe. If additional information is needed, our clinical team contacts you directly. Declined applications receive clear explanations and alternative recommendations where appropriate. This efficient process means Preston patients can begin treatment within 48 hours of initial consultation, subject to prescriber approval and medication stock availability[8].

Long-Term Support Through Our Weight Loss Clinic Preston Service

Successful weight loss requires ongoing clinical monitoring, which our weight loss clinic Preston service provides through regular follow-up assessments. GLP-1 treatments follow dose escalation protocols—Mounjaro increases from 2.5mg to 15mg over 20 weeks, whilst Wegovy escalates from 0.25mg to 2.4mg over 16 weeks. Each dose increase requires prescriber approval based on tolerability and weight loss progress.

Our pharmacist-led support includes side effect management guidance, injection technique videos, and dietary advice to optimise treatment outcomes. You can contact our clinical team on (+44) 116 4646009 with questions or concerns throughout your treatment journey. This comprehensive support structure ensures Preston patients receive the same ongoing care as traditional face-to-face weight loss clinics, but with the added convenience of remote access and flexible consultation scheduling.

Monitoring Weight Loss Progress and Treatment Adjustments

Clinical guidelines recommend continuing GLP-1 treatments only if patients achieve ≥5% weight loss after 12 weeks at maintenance dose. Our prescribers monitor your progress through regular assessments, adjusting treatment plans if weight loss plateaus or side effects become problematic. Some patients transition between treatments—for example, switching from Saxenda to Mounjaro for enhanced efficacy—whilst others combine medication with behavioural interventions for optimal results. Your treatment plan remains flexible and responsive to your individual response and changing health needs.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Guidance on online prescribing and remote consultations. MHRA. [accessed 30 September 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 30 September 2026]
3. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 30 September 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 30 September 2026]
5. General Pharmaceutical Council. (2023). Standards for registered pharmacies. GPhC. [accessed 30 September 2026]
6. National Institute for Health and Care Excellence. (2022). Semaglutide for managing overweight and obesity (TA875). NICE. [accessed 30 September 2026]
7. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care, 44(7), 1604-1612. [accessed 30 September 2026]
8. Royal Pharmaceutical Society. (2023). Professional guidance on remote consultations and electronic prescribing. RPS. [accessed 30 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 30 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 30 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 30 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.